The effects of salicylate on enzymes of vitamin K metabolism.
The mechanism of salicylate-induced hypoprothrombinaemia has been investigated in the rat. Salicylate administration produced an increase in the percentage of the total liver vitamin that was present as vitamin K 2,3-epoxide, but the addition of salicylate did not influence vitamin K epoxide reductase activity in-vitro. Neither did it influence vitamin K-dependent carboxylase or vitamin K epoxidase activity. Both cytosolic and microsomal DT-diaphorase activities were, however, inhibited about 50% by 75 microM sodium salicylate. Salicylate inhibition was also observed when vitamin K quinone and NADH or dithiothreitol were used to support carboxylation. To achieve 50% inhibition required 0.5 mM salicylate with NADH as a reductant and 4 mM salicylate when dithiothreitol was the reductant. These results suggest that the main effect of salicylate on vitamin K metabolism is to inhibit quinone reductases and may be useful in explaining the inhibition of the biosynthesis of vitamin K-dependent clotting factors that occurs in salicylate-induced hypothrombinaemia. These data also demonstrate that the percentage of total liver vitamin present as vitamin K epoxide can be increased by agents that do not have a direct effect on the vitamin K epoxide reductase in-vitro.
D000818:Animals; D008099:Liver / Q000378:metabolism; D008297:Male; D011516:Prothrombin / Q000378:metabolism; D051381:Rats; D012459:Salicylates / Q000494:pharmacology*; D020156:Salicylic Acid; D014812:Vitamin K / Q000031:analogs & derivatives / Q000378:metabolism*; D010837:Vitamin K 1 / Q000031:analogs & derivatives / Q000097:blood
D012459:Salicylates; D014812:Vitamin K; C016186:vitamin K1 oxide; D010837:Vitamin K 1; D011516:Prothrombin; D020156:Salicylic Acid